Drug Type Small molecule drug |
Synonyms Pifatidine, Roxatidine accetate hydrochloride, Roxatidine acetate hydrochloride (JP17/USAN) + [8] |
Target |
Mechanism H2 receptor antagonists(Histamine H2 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (18 Mar 2004), |
Regulation- |
Molecular FormulaC19H29ClN2O4 |
InChIKeyFEWCTJHCXOHWNL-UHFFFAOYSA-N |
CAS Registry93793-83-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D01467 | Roxatidine Acetate Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Duodenal Ulcer | KR | 25 Apr 2024 | |
Esophagitis, Peptic | KR | 25 Apr 2024 | |
Gastroesophageal Reflux | CN | 18 Mar 2004 | |
Hyperemesis Gravidarum | CN | 18 Mar 2004 | |
Peptic Ulcer | CN | 18 Mar 2004 | |
Zollinger-Ellison Syndrome | CN | 18 Mar 2004 |